Keywords
COVID-19
Hospital Emergency Department Síndrome Coronariana Aguda
Covid-19
Serviço Hospitalar de Emergência
Abstract
Objective: To assess the impact of the COVID-19 pandemic on response times and clinical outcomes of acute coronary syndrome admissions. Methods: Retrospective cohort study. Data were analyzed using SPSS® version 20.0 with parametric and non-parametric tests for group comparisons. Generalized linear modeling was used for multivariate analysis. Results: 434 patients were included in the pre-pandemic period and 430 during the pandemic period. Delta-t was higher during the pandemic period (p=0.003). There were no differences in response times and mortality. Admission during the pandemic period (RR 1.56; 95% CI: 1.30-1.87) and a previous diagnosis of ischemic heart disease (RR 1.82; 95% CI: 1.50-2.20) were associated with an increase in delta-t. Conclusions: There was no difference in the number of patients presenting to the emergency department with acute coronary syndrome during the periods analyzed. Despite longer Delta-t during the pandemic, no worse clinical outcomes were observed.
References
Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on st-segment–elevation myocardial infarction care
in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13(4):e006631. Available from: https://www.ahajournals.org/doi/epub/10.1161/CIRCOUTCOMES.120.006631 doi: https://doi.org/10.1161/CIRCOUTCOMES.120.006631
Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ. et al. Decline of acute
coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J. 2020 May 14; 41(19):1852-3. Available from: https://academic.oup.com/eurheartj/article/41/19/1852/5820829?login=false doi: https://doi.org/10.1093/eurheartj/ehaa314
Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. 2020 Apr 9. J Am Coll Cardiol. Pii:S0735- 1097(20_34912-5. Available from: https://www.sciencedirect.com/science/article/pii/S0735109720349135?via%3Dihub doi: https://doi.org/10.1016/j.jacc.2020.04.011
Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarctiopatientspresentingwith ST-segment elevation. EurHeart J. 2018;39:119–77. Available from: https://academic.oup.com/eurheartj/article/39/2/119/4095042?login=false doi: https://doi.org/10.1093/eurheartj/ehx393
Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39:1065–74. Available from: https://academic.oup.com/eurheartj/article/39/13/1065/4855284?login=false doi: https://doi.org/10.1093/eurheartj/ehy004
Wijns W, Naber CK. Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected. Eur Heart J. 2018 Apr 1;39(13):1075-1077. Available from: https://academic.oup.com/eurheartj/article/39/13/1075/4855285 doi: https://doi.org/10.1093/eurheartj/ehy069
Park J, Choi KH, Lee JM, Kim HK, Hwang D, Rhee TM, Kim J, et al. Prognostic Implications of Door-to-Balloon Time and Onset-to-Door Time on Mortality in Patients With ST -Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2019 May 7;8(9):e012188. Available from: https://www.ahajournals.org/doi/epub/10.1161/JAHA.119.012188 doi: https://doi.org/10.1161/JAHA.119.012188
Writing Committee Members, Dehmer GJ, Badhwar V et al. 2020 AHA/ACC Key data elements and definitions for coronary revascularization: a report of the American
College of Cardiology/American Heart Association Task Force on clinical data
standards (writing committee to develop clinical data standards for coronary revascularization). J Am Coll Cardiol. 2020 Apr 28; 75(16):1975-2088. Available from: https://www.sciencedirect.com/science/article/pii/S0735109720305210?via%3Dihub doi: https://doi.org/10.1016/j.jacc.2020.02.010
Chieffo A, Stefanini GG, Price S, et al. EAPCI position statement on invasivemanagement of acute coronary syndromes during the COVID-19 pandemic. Eur Heart J. 2020;41:1839–51. Available from: https://academic.oup.com/eurheartj/article/41/19/1839/5836093?login=false doi: https://doi.org/10.1093/eurheartj/ehaa381
Mesnier J, Cottin Y, Coste P, et al. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile. Rochester, NY: Social Science Research Network; 2020. Available from: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30188-2/fulltext doi: https://doi.org/10.1016/S2468-2667(20)30188-2
Hammad TA, ParikhM, Tashtish N, et al. Impact of COVID19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter. Catheter Cardiovasc Interv. 2021;97:208–14. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ccd.28997
doi: https://doi.org/10.1002/ccd.28997
Kwok CS, Gale CP, Kinnaird T, et al. Impact of COVID19 on percutaneous coronaryintervention for ST-elevation myocardialinfarction. Heart. 2020;106:1805–11.
Available from: https://heart.bmj.com/content/106/23/1805.long doi: http://dx.doi.org/10.1136/heartjnl-2020-317650
C-CF T,CheungK-S, Lam S, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment–elevation myocardial infarction care in Hong Kong, China. Circ CardiovascQualOutcomes. 2021;97:E194–7. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ccd.28943 doi: https://doi.org/10.1002/ccd.28943
ClaeysMJ, Argacha J-F, Collart P, et al. Impact of COVID-19- related public containment measures on the ST elevation myocardial infarction epidemic in Belgium: a nationwide, serial,cross-sectional study. ActaCardiol. 2021;76:863–9. Available from: https://www.tandfonline.com/doi/abs/10.1080/00015385.2020.1796035?journalCode=tacd20 doi: https://doi.org/10.1080/00015385.2020.1796035
CliffordCR, LeMayM, Chow A, et al. Delaysin ST-elevation myocardialinfarction care during theCOVID-19lockdown: anobservational study. CJCOpen. 2020;3:565–7. Available from: https://www.cjcopen.ca/article/S2589-790X(20)30219-5/fulltext doi: https://doi.org/10.1016/j.cjco.2020.12.009
Gluckman TJ, Wilson MA, Chiu S-T, et al. Case rates, treatment approaches, and outcomes in acute myocardial infarction during the coronavirus disease 2019 pandemic. JAMACardiol. 2020;5:1419. Available from: https://jamanetwork.com/journals/jamacardiology/fullarticle/2769293 doi: https://doi.org/10.1001/jamacardio.2020.3629
XiangD,XiangX,ZhangW,etal. Managementandoutcomes of patients with STEMI during the COVID-19 pandemic in China. JAmCollCardiol. 2020;76:1318–24. Available from:https://www.sciencedirect.com/science/article/pii/S0735109720357351?via%3Dihub doi: https://doi.org/10.1016/j.jacc.2020.06.039
De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. EurHeart J. 2020;41:2083–8. Available from: https://academic.oup.com/eurheartj/article/41/22/2083/5837572?login=false doi: https://doi.org/10.1093/eurheartj/ehaa409
Hannan EL, Wu Y, Cozzens K, Friedrich M, Tamis-Holland J, Jacobs AK, Ling FSK, King SB 3rd, Venditti FJ, Walford G, Berger PB, Kirtane AJ, Kamran M. Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York. Am J Cardiol. 2021 Mar 1;142:25-34. Available from: https://www.ajconline.org/article/S0002-9149(20)31295-9/fulltext doi: https://doi.org/10.1016/j.amjcard.2020.11.033
Bryndza MA, Litwinowicz R, Bartuś S, Nosal M, Godlewski J, Orzechowska A, et al. Incidence of mechanical complications following myocardial infarction during the first two months of the COVID-19 pandemic in the Southern Poland region: a multicenter study. Kardiol Pol. 2021 Jan 25;79(1):66-68. Available from: https://journals.viamedica.pl/kardiologia_polska/article/viewd?doi=10.33963/KP.15653
doi: https://doi.org/10.33963/kp.15653
Mesnier J, Cottin Y, Coste P, Ferrari E, Schiele F, Lemesle G, Thuaire C, Angoulvant D, et al. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. Lancet Public Health. 2020 Oct;5(10):e536-e542. Available from: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30188-2/fulltext
doi: https://doi.org/10.1016/S2468-2667(20)30188-2
De Luca G, Algowhary M, Uguz B, Oliveira DC; Collaborators et al. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction. Heart. 2022 Mar;108(6):458-466. Available from: https://heart.bmj.com/content/108/6/458.long doi: http://dx.doi.org/10.1136/heartjnl-2021-319750
Zuo, M., Xiang, S., Bhattacharyya, S. et al. Management strategies and outcomes of acute coronary syndrome (ACS) during Covid-19 pandemic. BMC Cardiovasc Disord 22, 242 (2022). Available from: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-022-02680-z doi: https://doi.org/10.1186/s12872-022-02680-z
Haddad K, Potter BJ, Matteau A, Gobeil F, Mansour S. Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter. Cardiovasc Revasc Med. 2021 Sep;30:33-37. Available from: https://www.sciencedirect.com/science/article/pii/S155383892030573X?via%3Dihub
doi: https://doi.org/10.1016/j.carrev.2020.09.024
Ramzy J, Martin CA, Burgess S, Gooley R, Zaman S. COVID-19 Pandemic Impact on Percutaneous Coronary Intervention for Acute Coronary Syndromes: An Australian Tertiary Centre Experience. Heart Lung Circ. 2022 Jun;31(6):787-794. Available from: https://www.heartlungcirc.org/article/S1443-9506(21)01340-8/fulltext doi: https://doi.org/10.1016/j.hlc.2021.10.019
Cinier G., Hayiroglu M., Pay L., Yumurtas A., Tezen O. & Parsova K. E. (2020). Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Turk Kardiyol Dern Ars., 48 (7), 640-645. Available from: https://archivestsc.com/jvi.aspx?un=TKDA-95845 doi: https://doi.org/10.5543/tkda.2020.95845
Little C. D., Tushar K., Luciano C., Richard J., George C., Asrar A., Connoly M., Ritesh K., Ozan M., Lucy L.O., Brian W., Sam F., Sprat J.C., Perera D.,MacCarthy P., Miles D., Ajain, J., Wilson S.J., Ikbal M. & Roby R (2020). COVID-19 pandemic and STEMI: pathway activation and outcomes from the pan-London heart attack group. Open Heart. 07 (02), 1-10. Available from: https://openheart.bmj.com/content/7/2/e001432.long doi: https://doi.org/10.1136/openhrt-2020-001432
Hauguel-Moreau M, Pillière R, Prati G, Beaune S, Loeb T, Lannou S, et al. Impact of Coronavirus Disease 2019 outbreak on acute coronary syndrome admissions: four weeks to reverse the trend. J Thromb Thrombolysis. 2021 Jan;51(1):31-32.
Available from: https://link.springer.com/article/10.1007/s11239-020-02201-9
doi: https://doi.org/10.1007/s11239-020-02201-9
Falcão JL, Rabelo DR, Falcão SN, Pereira Neto JA, Arnauld FC, Belém LS, et al. Impacto do isolamento social na pandemia de COVID-19 sobre atendimentos de emergência e angioplastias para infarto do miocárdio em hospital cardiológico. J Transcat Intervent. 2020;28:eA20200009. Available from: https://jotci.org/wp-content/uploads/articles_xml/2595-4350-jotci-28-eA20200009/2595-4350-jotci-28-eA20200009.pdf doi: http://dx.doi.org/10.31160/JOTCI202028A20200009
He L, Lu F, Du X, Long D, Sang C, Tang R, Dong J, Guo M, Ma C. Impact of COVID-19 Pandemic on Hospital Admissions of Acute Coronary Syndrome: A Beijing Inpatient Database Study. Lancet Reg Health West Pac. 2022 Feb;19:100335. Available from: https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(21)00244-3/fulltext
doi: https://doi.org/10.1016/j.lanwpc.2021.100335
Kitahara S, Fujino M, Honda S, et al COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction Open Heart 2021;8:e001497. Available from: https://openheart.bmj.com/content/8/1/e001497.long doi: https://doi.org/10.1136/openhrt-2020-001497
Hauguel-Moreau M, Pillière R, Prati G, Beaune S, Loeb T, Lannou S, Mallet S, Mustafic H, Bégué C, Dubourg O, Mansencal N. Impact of Coronavirus Disease 2019 outbreak on acute coronary syndrome admissions: four weeks to reverse the trend. J Thromb Thrombolysis. 2021 Jan;51(1):31-32. Available from: https://link.springer.com/article/10.1007/s11239-020-02201-9 doi: https://doi.org/10.1007/s11239-020-02201-9
Watanabe Y, Miyachi H, Mozawa K, Yamada K, Oka E, Shiomura R, Sugizaki Y, Matsuda J, Nakata J, Tara S, Tokita Y, Iwasaki YK, Yamamoto T, Takano H, Shimizu W. Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo. Intern Med. 2021 Dec 1;60(23):3693-3700. Available from: https://www.jstage.jst.go.jp/article/internalmedicine/60/23/60_8220-21/_article doi: https://doi.org/10.2169/internalmedicine.8220-21
Fileti L, Vecchio S, Moretti C, Reggi A, Aquilina M, Balducelli M, Santarelli A, Grosseto D, Piovaccari G, Rubboli A. Impact of the COVID-19 pandemic on coronary invasive procedures at two Italian high-volume referral centers. J Cardiovasc Med (Hagerstown). 2020 Nov;21(11):869-873. Available from: https://journals.lww.com/jcardiovascularmedicine/Fulltext/2020/11000/Impact_of_the_COVID_19_pandemic_on_coronary.5.aspx doi: https://doi.org/10.2459/jcm.0000000000001101
Boeddinghaus J, Nestelberger T, Kaiser C, Twerenbold R, Fahrni G, Bingisser R, Khanna N, et al. Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland. Int J Cardiol Heart Vasc. 2020 Dec 4;32:100686. Available from:https://www.sciencedirect.com/science/article/pii/S2352906720303845?via%3Dihub doi: https://doi.org/10.1016/j.ijcha.2020.100686
Rodriges JA, Melleu K, Schmidt MM, Gottschall CAM, Moraes MAP, Quadros AS. Preditores de Apresentação Tardia em Pacientes com Infarto Agudo do Miocardio com Supradesnivelamento do Seguimento ST. Arq. Bras. Cardiol. 2018;111(4) : 587 – 93. Avaiable from: https://abccardiol.org/article/preditores-de-apresentacao-tardia-em-pacientes-com-infarto-agudo-domiocardio-com-supradesnivelamento-do-segmento-st/
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Array